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IndiaAbstract India has a rapidly growing population inflicted with cancer diagnosis. From an esti-
mated incidence of 1.45 million cases in 2016, the cancer incidence is expected to reach 1.75 million
cases in 2020. With the limitation of facilities for cancer treatment, the only effective way to tackle
the rising and humongous cancer burden is focusing on preventable cancer cases. Approximately,
70% of the Indian cancers (40% tobacco related, 20% infection related and 10% others) are caused
by potentially modifiable and preventable risk factors. We review these factors with special empha-
sis on the Indian scenario. The results may help in designing preventive strategies for a wider appli-
cation.
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Globally, cancer is increasingly being recognized as a major
contributor to health concerns. The increasing age of popu-
lations, especially in the developing regions is an important
factor, as cancer incidence increases directly with age. How-
ever, in India and similar countries, recent advancements in
access to health care and therefore diagnosis are also impor-
tant in documenting the role of cancer as a health problem.
An estimated 13 million cancer cases are reported per year
worldwide, and roughly 60% of these cases are expected to
die in developing countries [1]. As per WHO projections,
the death toll of cancer would reach 10 million cases per
year worldwide by the year 2020. As per the recent esti-
mates by India’s National Cancer Registry Program
(NCRP), 1.45 million cases would occur in 2016 with 0.74
million deaths in India. This is expected to rise to 1.73 mil-
lion cases and 0.88 million deaths in 2020 [2]. Thus, one in
8 men and one in 9 women are expected to suffer from can-
cer [2] in their lifetime (considering a median life expectancy
of 74 years).
Major potentially modifiable lifestyle factors include
tobacco consumption in various forms, infections, dietary
factors (which may be underestimated) and alcohol use. It
is estimated that 35–50% of the cancer cases worldwide
can be prevented by control of potentially modifiable fac-
tors [3,4]. While we acknowledge that variation in registry
quality likely affects these results, we are struck by the
observation that there is a wide geographic variation of
cancer incidences among various cancer registries of India
[2]. Aizwal (Capital of Mizoram state) records the highest
cancer incidence in India of 270/100,000 population as com-
pared to 40/100,000 population for Barshi (a rural area in
Solapur district of Maharashtra state). Possibly, these wide
variations implicate potentially controllable variations in
lifestyle factors contributing to cancer risk. Such lifestyle
variations might include variation in tobacco consumption,
dietary factors and environmental factors that could be
modified by targeted programs.
The etiological factors for preventable cancers may show
wide country specific variations. Skin cancers (related to sun-
exposure) are common in the western population but rare in
Indians. Difference in patterns of tobacco consumption
(smoked versus smokeless tobacco), alcohol consumption
(spirits versus wines), and diet (less non-vegetarian and less
consumption of red meat) leads to differences in incidence of
related cancers too and mandates an India-centric approach
to cancer prevention. In this article, we aim to discuss the bur-
den of preventable cancer with special emphasis on the Indian
scenario.Please cite this article in press as: Gandhi AK et al. Burden of preventable cancers i
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80% of the tobacco consumers reside in economically develop-
ing countries where there is little push to encourage prevention
or help those who are already smokers. Many of them are of
younger age group [3], especially men, but in India, where betel
use is often combined with tobacco, it is important to acknowl-
edge the contribution of smokeless tobacco in both men and
woman. The incidence of tobacco related cancers varies widely
as per geographic location and gender in India. 30–60% of
total cancers among males and 10–30% among females are
tobacco related by one estimate [2], so that 1 in 17 males
and 1 in 50 females have a lifetime risk of tobacco related can-
cers in India [2]. This directly corroborates with a low propor-
tion of tobacco consumption among females in India [5].
Alarmingly, 15% of the youth (age group 13–15 years) use
tobacco in some form as per the Global Youth Tobacco Sur-
vey (GYTS 2009–10) [6]. Overall, 35% of adults (ageP 15 -
years; including 48% of males and 20% of females) use
tobacco [5], typical as smoked tobacco (14% of adults; 25%
of males and 3% of females) but 33% of males and 19% of
females use smokeless tobacco (with or without smoking).
Tobacco increases the risk of lung cancer as well as 15 other
cancers and is the forerunner of preventable causes of cancer
deaths accounting for 21% of total cancer deaths worldwide
[3]. It is the strongest risk factor for lung cancer (increasing
risk by 10–20-fold for this extraordinarily lethal cancer) and
also it has been implicated as a contributing etiological agent
for head and neck cancers (oral cavity, nasal cavity, paranasal
sinuses, nasopharynx, larynx, and hypopharynx), esophagus,
stomach, colorectal, pancreatic, hepatocellular, bladder, kid-
ney, cervical cancers and leukemia [7].
Yet another challenge in India is areca nut chewing along
with betel leaves (locally known as pan) and which most times
is stuffed with smokeless tobacco. Betel quid usage prevalence
has been found to range from 20 to 40% in the Indian popu-
lation [8]. Sweetened areca nut chewing habit has been found
in school going children. Khandelwal et al. [9] in their study
on 3896 children, found 27% chewing areca nut and mostly
(80% of these) used sweetened form of it. Most of these chil-
dren are unaware of the harmful effects of these habits.
Daily consumption of ten or more quids of pan-tobacco
increases the risk of cancers of gingiva; the relative risk among
males and females being 15.07 and 13.69, respectively [10].
Pan-tobacco habit of more than 40 years’ duration also has a
relative risk of 2.03 of developing carcinoma of esophagus [11].
It is important to note that tobacco cessation has many
health benefits apart from prevention of cancer, such as in
reducing cardiovascular and pulmonary diseases. Quitting
smoking before 50 years of age reduces the risk of death byn India: Time to strike the cancer epidemic, J Egyptian Nat Cancer Inst (2016),
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Tobacco cessation depends on a complex interplay of personal
awareness, socio-cultural habits and governmental legislative
actions. Strategies of tobacco control as advocated by WHO
has been implemented by several countries including India.
This includes a six-pronged strategy of MPOWER (Monitor
tobacco use and prevention policy, Protect people from
tobacco smoke, Offer help to quit tobacco, Warn about dan-
gers of tobacco smoking, Enforce ban on tobacco advertising,
promotion and sponsorship, Raise tax on tobacco). COTPA
(Cigarette and other tobacco products Act 2003) states provi-
sions for restriction of sale and use of tobacco products in
India [13]. 18 Tobacco Cessation Centers (an initiative by
WHO and supported by Govt. of India) are operational in var-
ious parts of country and is co-ordinated by National Institute
of Mental Health and Neurosciences, Bangalore. The National
Drug Dependence Center of All India Institute of Medical
Sciences, New Delhi caters not only to the clinical care but also
to community programs, education and research in this arena.
These programs depend on the enthusiasm and financial
support of governmental agencies, but individual health care-
takers, such as doctors, nurses and medical officers have much
to contribute, having the direct interaction with the subject.
Simply mnemonic may be helpful to keep in mind. At an indi-
vidual level, for those who seek to quit, 5 ‘‘A” method should
be used (Ask, Advise, Assess, Assist and Arrange) and for
those not yet willing to quit, 5 ‘‘R” method should be used
(Relevance of quitting, Risk of continuing tobacco, Rewards
of quitting, Roadblocks to quitting and Repeat these at each
visit). Depending on the level of addiction and motivation of
the users to quit, behavioral counseling or pharmacotherapy
or a combination of both may be required. Lastly, the efforts
and practices for tobacco cessation should also apply to betel
quid chewing (which as discussed is also of a major concern in
the Indian population).
Alcohol
As per an estimate by WHO [14], 30% of total population in
India consumed alcohol (compared to a global figure of
38.3%). The per capita consumption has increased from
1.6 liters in 2003–2005 to 2.2 liters in 2010–2012. As compared
to global figures of 16%, heavy/binge drinking was noted in
11% of population.
Alcohol contributes to around 4% of all cancers world-
wide. Alcohol consumption leads to increased risk of squa-
mous cell carcinoma of mouth, pharynx, larynx, and
esophagus in multiple studies and the reports have been fairly
consistent. Risk for some other cancers like adenocarcinoma
of esophagus, gastro-esophageal junction, gastric cardia,
colon, rectum and pancreas has also been found to be
increased with alcohol [15].
A prospective study [16] found an increased risk by 6% per
consumption of 10 g/day of alcohol. Its use increased the risk
of oropharynx, larynx, esophagus, rectum, liver and breast can-
cers (study restricted to women). The EPIC study (The Euro-
pean Prospective Investigation into Cancer and Nutrition)
found 10% attributable cancer risk associated with alcohol in
men and 3% inwomen [17]. In this study, high alcohol consump-
tion was set at 2 or more drinks per day (24 g of alcohol) in men
and 1 or more drink per day (12 g of alcohol) for women.Please cite this article in press as: Gandhi AK et al. Burden of preventable cancers in
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the Indian population are limited. Sankaranarayanan et al.
found significantly (p< 0.001 for all these studies) increased
risk of gingival cancers [18], esophageal cancers [11] and laryn-
geal cancers [19] with alcohol consumption in their case–con-
trol studies; relative risk being 2.62, 2.33 and 2.58
respectively for gingival, esophageal and laryngeal cancers.
Laws enforced by the government for limiting alcohol use
includes heavy excise tax on sale of alcohol, fixing the legal
age for consumption and prohibition of alcohol use in certain
states of country. However, the law varies from state to state.
The pattern of alcohol consumption in India has shown a tran-
sition over the last 3–4 decades. While, alcohol drinking and
abuse was limited to poor socio-economic class, now alcohol
is being propagated as a mark of the affluent society. Peer pres-
sure and social cultures are making the dynamics of alcohol
consumption complex. Most of the efforts by government
and non-government organizations focus on tobacco; aware-
ness and educational programs pertaining to harmful effects
and restriction of alcohol should be propagated. Putting con-
straints on hours of sale, days of sale, sale around premises
of school, colleges and institutions may also be helpful as ini-
tial constraint measures. Putting specific warning labels (simi-
lar to that on cigarettes) on alcoholic packaging, restricting
advertisement and sponsorship and regulating prices of alco-
holic drinks as compared to local beverages could be a further
stepping stone toward a better alcohol control policy.
Infections
Infection related cancers (example: stomach, cervix, hepatocel-
lular) accounts for around 20–25% of all the cancer cases
worldwide, but the burden is especially high in the developing
world where infection-prevention practices are limited,
wherein 80% of these cases reside [1].
Most common infections associated with cancer are viruses
and include Human Papilloma virus (HPV), Hepatitis B & C,
Human T-cell lymphotropic virus (HTLV-1), Human Immun-
odeficiency virus (HIV), Human herpes virus 8 and Epstein-
Barr virus. However, non-viral infections are important,
prominently including Helicobacter pylori and some hel-
minthes (Opisthorchis viverrini, Clonorchis sinensis and Schisto-
soma haematobium).
Data from the Indian population addressing specifically at
infections related cancers are sparse. HPV related cancer inci-
dences in India are provided by ICO (InstitutCatala`d’Oncolo
gia) Information center on HPV [20]. As per the report, the
proportion of cancers considered HPV related in India varies
from 20% (cervical cancers) to <1% for anal and vaginal/
vulva cancers. HPV related head and neck cancers are reported
to be 5% among males and 1.1% among females. The impor-
tance of cervical cancer deserves special mention. In cervical
cancers, 80–85% have HPV 16/18 detected, emphasizing its
importance in the etiology of this cancer. While early recogni-
tion often leads to cure, too few women are identified as at
risk.
India has 34 million carriers of Hepatitis B, an extraordi-
nary frequency which accounts for 10–15% of world’s carrier
population [21]. Considering the risk of hepatocellular carci-
noma in carriers of hepatitis B and C (approximately 1–3%
over 30 years), the future burden of these cancers will likelyIndia: Time to strike the cancer epidemic, J Egyptian Nat Cancer Inst (2016),
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and very likely to be fatal.
Approximately, 2.4 million Indians are said to be living
with HIV, likely an underestimate. Non-Hodgkin lymphoma
are most common among HIV associated malignancy and risk
of cervical, anal, vulva/vaginal and penile cancer risk appear to
be increased based on limited data from the Indian population
[22]. The incidence of Kaposi sarcoma seems to be low in the
Indian population [23].
The prevalence of Helicobacter pylori infection has been
found to be high (50–80%) in the Indian population not cor-
roborating with the incidence of gastric cancers and this is
known as ‘‘Indian Enigma” [24]. This could partly be because
of the mildly pathogenic variants of bacteria (NAB47 and
NAD1) in the Indian population and also because of other fac-
tors (like dietary, tobacco and socio-economic status) which
may overwhelm and at times mask the effect of this oncogenic
infection [24].
Majority of infections causing cancers are transmitted sex-
ually (HPV, hepatitis and HIV). Practicing safe sex would help
to prevent majority of these infections. Sexual education as a
part of elementary education and inculcating concepts of safe
sexual practices among individuals through IEC (information
education and communication) systems should be promoted.
Promotion of use of condoms are already advertised as means
to reduce HIV infections; addition of information that this
would also prevent potential risk of development of cancer
would increase awareness as well as may increase their use in
population at large. These oncogenic infections are also spread
by infected blood or body fluids, wherein minimal exposures
have a high transmission risk. Unsanitary office, clinic and
hospital practices will contribute to this transmission. Follow-
ing universal guidelines for screening and transfusion of blood
and blood products, and especially, using disposable needles
and syringes will greatly help reduce exposure. Effective vacci-
nation strategies also exist for Hepatitis and HPV infections
but are expensive in areas of limited resources. Use of highly
active anti-retro viral therapy (HART), interferon and nucle-
oside/tide analogs decreases viral loads in HIV and hepatitis
and impact on the transmission of these onco-viruses in the
population (as well as having major treatment benefits, includ-
ing reduction in cancer risk).Physical inactivity, diet and obesity
At least 6 cancers (colorectal, breast, stomach, liver, kidney
and endometrial) have direct links with unhealthy diets, phys-
ical inactivity and obesity [25], although we acknowledge that
the evidence is only association, not causal. Where interven-
tions would change cancer risk is unclear, because poor diet/
inactivity is associated with many other lifestyles that increase
cancer risk (e.g., smoking). Prospective intervention studies are
difficult to conduct in the population.Physical inactivity
5% of cancer deaths are attributable to physical inactivity.
Evidence supporting reduction of risk with an increase in phys-
ical activity is the strongest with breast, colo-rectal cancers and
endometrial cancers while there are still some data to suggest aPlease cite this article in press as: Gandhi AK et al. Burden of preventable cancers i
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cancers.
Dallal et al. [26] reported association between recreational
physical activity and risk of invasive/in-situ breast cancer in
California Teachers Study. Women with strenuous activity
(>5 vs. <=0.5 h/week/year) had statistically significant
reduction of both invasive (RR 0.80; 95% CI 0.69–0.94;
p= 0.02) as well as in-situ breast cancer risk (RR 0.69; 95%
CI 0.48–0.98; p= 0.04). Overweight women in this study also
showed lower risks of breast cancer death irrespective of estro-
gen receptor status and disease stage (RR 0.53; 95% CI, 0.35–
0.80) [19]. A meta-analysis of 52 studies [27] showed an inverse
association between physical activity and colon cancer (RR of
0.76; 95% CI: 0.72, 0.81). Voskuil et al. [28] in a systemic
review of studies which included 7 cohort and 13 case–control
studies found a majority (80%) of 10 high quality studies
showed a risk reduction of >20%.
Ambivalent findings
Daily total physical activity was associated with fewer inci-
dences of carcinoma stomach, colon, liver and pancreas in a
Japanese public health center prospective study [29]. Antonelli
et al. [30] in a prospective cohort of 190 men undergoing pro-
static biopsy found a lower likelihood of positive biopsy result
in men performing at least 9 or more metabolic equivalent task
(MET) hours/week (OR 0.35, CI 0.17–0.75, p= 0.007) and
they were also less likely to have higher grade of disease (Glea-
son 7 or greater, OR 0.14, CI 0.02–0.94, p= 0.04).
In contrast, Patel et al. [31] evaluated men from the Amer-
ican Cancer Society Cancer Prevention Study II Nutrition
Cohort and based on 5503 prostate cancers reported in
72,174 men found no association between recreational physical
activity and prostate cancer risk. However, >35 MET/week
was associated with less aggressive prostate cancers as com-
pared to those with no activity (RR, 0.69; 95% confidence
interval, 0.52–0.92; P for trend = 0.06). There is also some
suggestion that this benefit could be limited to particular racial
groups like whites as compared to blacks. Singh et al. [32]
reported in their prospective study on 307 men that the whites
with P9 MET/week were less likely to receive a positive
biopsy result as compared to those with <9 MET/week (OR
0.47; 95% CI, 0.22–0.99; P= 0.047), however the same was
not true for the black population.
Studies on the Indian population are limited in this aspect.
Mathew et al. [33] evaluated the role of household activities
(HA) in the development of breast cancer. Odds ratio for
P6 h/day spent on HA as compared to 3 h/day was 0.70 for
premenopausal and 0.51 for postmenopausal women. As per
the study, it is estimated that proportion of breast cancers
avoided in urban and rural women with moderate or high
HA could be as high as 19% and 38% respectively.
Diet
A variety of food has been studied in relation to cancer. Diet-
ary fat (some association with prostate cancer), dairy products
(ovarian cancer), soy (decreased risk of breast cancer with
20 mg per day of isoflavone), fruits (decreased risk of prostate
cancer with lycopene), vegetables and fibers have all shown
weak association and controversial results in various studies
and have not been shown to affect cancer risk [34]. Vitaminsn India: Time to strike the cancer epidemic, J Egyptian Nat Cancer Inst (2016),
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cancer causation and prevention [35]. Vitamin D (serum
levels > 25 nmol/L) and Calcium intake (1200 mg/day) may
confer doubtful protection against colon cancers. Beta-
carotene (increases risk of lung cancers), Vitamin E (increase
risk of prostate cancer), selenium (decreased risk of overall
cancer) have all failed to establish a clear association with can-
cer etiogenesis or prevention.
Although the mechanism of carcinogenicity of red (pork,
beef, and lamb) and processed meat (sausages, hot dogs, bacon
and salami) is not clear, studies have shown an association
with increased risk of colo-rectal cancers. The International
Agency for Research in Cancer (IARC) working group [36]
reported an increased risk by 17% per 100 g/day of red meat
and 18% per 50 g/day of processed meat for colon cancer
and identified these as potential carcinogens. Red meat (HR
1.22, 95% CI 1.16–1.29) and processed meat (HR 1.12, 95%
CI 1.06–1.19) were also associated with elevated risk for cancer
mortality [37]. This might be of more concern in the western
population as compared to the Indian population (consump-
tion of red and processed meat is <20%).
Indian diet and cancer
The Indian diet is unique owing to its diversity, cultural and
religious practices. Turmeric (Curcumin) and other spices
and food additives (cumin, chillies, Kalakhar, Amrita Bindu,
etc.) have been found to have cancer preventive properties
[38]. Curcumin (a component of the Indian spice Turmeric),
cumin seeds and basil leaves have been found in animal studies
to have significant suppressive effect on cancer induction by
dietary benzopyrene [39,40]. Amrita Bindu (a salt-spice-
herbal mixture) has been found to protect rats against cancer
induced by N-methyl-N-nitrosoguanidine [41]. Vegetarian diet
(primarily composed of cereals and pulses) forming the major
diet of Indians have been found to be associated with low can-
cer risk as compared to a non-vegetarian diet [42,43].
Deep fried cooking at high temperature (which generates
polycyclic aromatic hydrocarbons), dried fish (consumed in
parts of South India and Eastern part of India), and spicy food
have been implicated in causation of stomach cancer in the
Indian population [44,45]. Carcinoma esophagus has been
found to be in high prevalence in the north eastern part ofTable 1 Compares and contrasts the modifiable risk factors
for causation of cancer in the western and Indian population.
Developed world (western
population)
Developing Country (Indian
population)
 Tobacco smoking (cigarettes
and cigars)
 Alcohol (spirits, wine)
 Red and processed meat
 Obesity (body mass
indexP 30 kg/m2)
 Human immunodeficiency
virus, Hepatitis virus,
Human Papilloma virus
associated head and neck
cancers (in that order)
 Sun exposure associated skin
cancers
 Smokeless tobacco in vari-
ous forms; smoked tobacco
 Alcohol (local made, spirits)
 Deep fried, salted fish, spicy
food
 Obesity (body mass
indexP 25 kg/m2)
 Human Papilloma virus
associated cervical cancer,
Human immunodeficiency
virus, Hepatitis virus (in that
order)
 Uncommon in Indian
population
Please cite this article in press as: Gandhi AK et al. Burden of preventable cancers in
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consumption of betel quid chewing, sun dried vegetables, chil-
lies and spicy food [46,47]. Rajkumar et al. [48] noted a high
risk of oral cavity cancers in subjects who consumed meat,
ham or salami (processed and fried meat) two or more times
a week.
Obesity
36% American adults and 17% of American children are
obese [49]. Although, obesity has not been a concern in the
Indian population until recently, the scenario is changing. As
per the National Family Health Survey [50], 12% of males
and 16% of females in India are either obese or overweight
and this may further increase in future. It has also been
reported that body mass index (BMI) may not be a true repre-
sentative of burden of obesity and ill effects of obesity might be
evident even at a lower BMI (P25 kg/m2) in the Indian popu-
lation and this may be an increasing concern [51].
Obesity (BMI of P30 kg/m2) has been associated with
increased risk of several cancers including non-Hodgkin’s lym-
phoma, leukemia, multiple myeloma, and cancers of the kid-
ney, colon, rectum, breast (in postmenopausal women),
pancreas, ovary, and prostate [52]. It accounts for approxi-
mately 8% (10% in men and 6% in women) of all cancers.
A meta-analysis of prospective observational studies [53] sug-
gested strong association of esophageal adenocarcinoma, thy-
roid cancer and renal cancers in men and endometrial and gall
bladders cancers additionally in women with an increase in
BMI of 5 kg/m2. Based on a large population based cohort
study of 5.2 million UK adults, it is estimated that around
41% of all endometrial cancers and 10% or more of gallblad-
der, kidney, liver, and colon cancers were associated with
excess weight [54]. An increase in population wide BMI by
1 kg/m2 could lead to an increase in annual cancer cases by
4000 patients [54], if this association is truly etiological.
Singh et al. in a hospital based matched case–control study
on the Indian population found that overweight (BMI 25–
29.9) and obese (BMIP 30) have an odds ratio of 1.06 and
2.27 respectively as compared to normal weight women in
developing breast cancer [55].
Screening and preventive strategies: India centric approaches
The modifiable risk factors may have different priorities in the
western and Indian population (Table 1) and region-specific
approaches may be needed. The diversity in socio-economic
strata, health care policy prioritization and public health deliv-
ery system in India may pose difficult challenges in implement-
ing the screening and preventive strategies established in the
western world. In this section, we discuss strategies tailored
to the Indian population based on evidence.
Results of screening and preventive trials in India
Carcinoma of breast, uterine cervix and lip and oral cavity
together constitutes around 34% of all cancers in India [56].
Although limited studies are available, the results nevertheless
are promising in some regard.
In a cluster randomized trial, Sankaranarayanan et al.
reported a reduction in cancer incidence by 25% and cervicalIndia: Time to strike the cancer epidemic, J Egyptian Nat Cancer Inst (2016),
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visual inspection with acetic acid by a trained health care per-
sonnel [57]. Another large scale study showed a reduction in
cervical cancer mortality with a rate ratio of 0.69 (p= 0.003)
after 12 years of follow up and four rounds of screening with
acetic acid and visual inspection [58]. Sankaranarayanan
et al. showed a 53% reduction in advanced cervical cancer
diagnosis and 48% reduction in deaths compared to standard
group in women (30–59 years) screened with single round of
HPV testing [59].
Oral cancer screening with visual inspection by a trained
health worker (three rounds at three year intervals) showed a
reduction in oral cancer incidence of 38% and 81% reduction
in mortality (in those who complied to all the three rounds) as
compared to the control group [60].
Sankaranarayanan et al. recently reported on the impact
and immunogenicity of HPV vaccination in girls in India
[61]. Unmarried girls aged 10–18 years were recruited in this
study and were planned to receive 3 doses of quadrivalent
HPV vaccine on days 1, 60 and 180 or 2 doses on day 1 and
60. However, because of a variety of reasons, many girls
received 1 or 2 doses of vaccine alone. Immune response of 2
doses were found to be non-inferior to 3 doses and also did
not show any difference in the incident cases of cervical carci-
noma in these groups.
Cost effectiveness of preventive strategies in India
Although, cost effectiveness analysis pertaining to India alone
is not available, Goldie et al. used computer based models to
assess the cost effectiveness of cervical cancer screening strat-
egy in five developing countries including India. The authors
estimated screening women once in their lifetime at the age
of 35 years (with a one-visit or two visit screening involving
visual inspection of cervix with acetic acid or DNA testing
for HPV in cervical cell samples) may lead to a reduction in
lifetime risk by 25–36% and would cost less than 500 United
States Dollars (USD) per year of life saved [62]. Oral cancer
screening by visual inspection by a trained health care worker
would cost less than six USD per persons (over approximately
10 years) and could lead to incremental (i.e. the difference
between intervention and control arms) cost per life year saved
of 835 USD for all individuals and 156 USD for high risk indi-
viduals [63].
An analysis by Okonkwo et al. showed that estimated cost-
effectiveness ratio for a single clinical breast examination
(CBE) in women of age group 40–60 could be 793 US Dollars
per life year gained and 1341 US Dollars per life year gained if
CBE was done biennially in the same age group [64].
Resource stratified strategies for the Indian scenario
Based on the results of the studies done on the Indian popula-
tion and the cost-effectiveness of the techniques, we could rec-
ommend strategies suited to needs and resources of our
country [65]. Conventional Pap smear and HPV testing consid-
ered the standard screening method for carcinoma cervix may
not be applicable to the Indian scenario. A practical approach
could be screening with visual inspection and acetic acid in
women aged 30–49 years and HPV testing in those more than
30 years of age (as permitted by the available resources).Please cite this article in press as: Gandhi AK et al. Burden of preventable cancers i
http://dx.doi.org/10.1016/j.jnci.2016.08.002Efforts should be made to screen women at least once in their
lifetime after 30 years of age.
Oral cancer screening with visual inspection by a trained
auxiliary health care worker could be a cost-effective screening
policy. Individuals at high risk (those consuming tobacco
products, alcohol or betel nut) in a specific age group (30–
60 years) could be given most priority. These individuals
(because of their tobacco and alcohol behavior) are also at
increased risk for non-communicable diseases (NCDs) and
hence, this screening opportunity can be used to screen them
for common NCDs like hypertension and diabetes mellitus.
Based on the studies on the Indian population, in lieu of the
mammographic screening, clinical breast examination every
5 years or biennially is predicted to reduce breast cancer mor-
tality rates by 8% and 16% respectively and this could also be
done in an inexpensive manner [64]. CBE with diagnostic
ultrasonography could be an approach in women younger
than 50 years of age. If resources permit use of screening with
mammography, women aged 50–65 years should be given
preference.
As supported by the study on Indian girls [61], 2 doses of
quadrivalent HPV vaccination (6 months apart) could be a
realistic and sustainable approach toward widespread
application.
Government initiative for preventable cancers in India:
integrative approach
NCDs accounts for 60% of all the death worldwide. In India,
it accounts for around 50% of all deaths and cancer accounts
for 1/5th of all NCDs [66]. Keeping in view the common risk
factors for NCDs, Government of India (GOI) has merged
the National Cancer Control Program into NPCDCS
(National Programme for Prevention and Control of Cancer,
Diabetes, Cardiovascular Disease and Stroke) with an aim to
prevent and control common NCDs through behavior and life-
style changes, to provide early diagnosis and management of
common NCDs, to build capacity at various levels of health
care facilities for prevention, diagnosis and treatment of com-
mon NCDs, to develop trained human resource within Public
Health set up and to establish and develop capacity for pallia-
tive & rehabilitative care. 100 districts are expected to be
strengthened for early detection and management of cancers
and over 1000 health personnel in various categories of man-
power would be trained. This would also provide baseline data
about cancer incidence at district and state levels which would
further help in designing effective strategies effectively focused
on preventable causes of cancers in India.
Conclusion
A multipronged strategy is needed to tackle the growing bur-
den of cancer in India and striking the preventable cancer bur-
den could be the best long term approach. Preventable cancers
could comprise up to 60–70% of the total cancer burden in
India. Concerns specific to the Indian population are smoke-
less tobacco, areca nut chewing (often with tobacco), country
made liquors and infections (mostly ano-genital HPV and
Hepatitis). Unique dietary habits (deep fried and spicy food)
coupled with increasing burden of obesity and a propensity
of the population toward physical inactivity is also a growingn India: Time to strike the cancer epidemic, J Egyptian Nat Cancer Inst (2016),
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vaccination strategies are further hurdles in inciting an attack
on these preventable cancers.
Tobacco control law and program needs to be prioritized
and implemented effectively across all states of the country.
Apart from government initiatives, advocacy by civil society
and efforts of non-government organizations also needs to
be promoted in this regard. Cost-effective strategies for screen-
ing could include screening of women (30–49 years of age) with
visual inspection and acetic acid; oral cancer screening with
visual inspection by a trained health care worker in high risk
individuals; and clinical breast examination biennially in speci-
fic age groups (40–60 years). Although, this strategy is not evi-
dence based, this could be an inexpensive, practical and
resource stratified approach. Similarly, one or two doses of
quadrivalent HPV vaccine in girls (9–26 years) could be a
widely applicable vaccination strategy.
In summary, the unique challenges of preventable cancer
burden in India may be dealt with indigenous and India-
specific approaches which may result in a sustainable long term
control of cancer.
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